Skip to content

CVRx, Inc. CVRX Other Commercial Liabilities

Other Commercial Liabilities at other companies

Boston Scientific logo
Boston ScientificBSX
Neuropace, Inc. logo
Neuropace, Inc.NPCE
Inspire Medical Systems logo
Inspire Medical SystemsINSP
LivaNova logo
LivaNovaLIVN
Merit Medical Systems logo
Merit Medical SystemsMMSI
Neuronetics logo
NeuroneticsSTIM

Other financials

Income statement

See full
Revenue$14.8M+19.6%
Gross profit$12.9M+24.9%
Operating income-$12.2M+9.5%
Net income-$13.1M+4.7%
EPS (diluted)-$0.50+5.7%

Balance sheet

See full
Cash & equivalents$72.3M-29.6%
Total debt$59.4M+17.8%
Total equity$29.1M-58.0%
Total assets$99.7M-23.0%

Cash flow

See full
Operating cash flow-$12.2M+4.7%
CapEx$122.0K+7.0%
Free cash flow-$12.3M+4.6%

Valuation

See full
Market cap$148.6M-2.9%
Enterprise value$135.69M+25.0%
P/S2.5×-0.3×

Profitability

See full
Gross margin86.2%+2.7pp
Operating margin-84.6%-8.9pp
Net margin-89.1%-7.0pp
FCF margin-68%-8.1pp

Returns & leverage

See full
Return on equity-107%+73.4pp
Debt / equity+1.3×
Current ratio10.2×-4.6×

Where this comes from

Reported directly by CVRx, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: CVRx, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about CVRx, Inc.'s other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CVRx, Inc.'s other commercial liabilities?
CVRx, Inc. (CVRX) reported other commercial liabilities of $6.49M in Q1 2026.
How has CVRx, Inc.'s other commercial liabilities changed year-over-year?
CVRx, Inc.'s other commercial liabilities increased by 12.7% year-over-year, from $5.76M to $6.49M.
What is the long-term trend for CVRx, Inc.'s other commercial liabilities?
Over 5 years (2020 to 2025), CVRx, Inc.'s other commercial liabilities has grown at a 21.5% compound annual growth rate (CAGR), from $3.58M to $9.48M.